feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / FDA OKs Altria's On! Nicotine Pouches

FDA OKs Altria's On! Nicotine Pouches

20 Dec, 2025

•

Summary

  • FDA authorized six Altria-owned on! PLUS nicotine pouch products.
  • Authorization came via a pilot program for fast-tracked reviews.
  • Products are considered lower risk than other smokeless tobacco.
FDA OKs Altria's On! Nicotine Pouches

The U.S. Food and Drug Administration announced on December 19, 2025, that it has authorized the marketing of six Altria-owned on! PLUS nicotine pouch products. This significant decision was made through a pilot program established in September 2025, specifically aimed at expediting reviews for these types of products.

These authorized on! PLUS nicotine pouches, manufactured by Helix Innovations LLC, are now legally available to adults in the United States. The approval covers mint, tobacco, and wintergreen flavors, offered in both 6 mg and 9 mg nicotine strengths. The FDA based its authorization on evidence indicating that these products contain lower levels of harmful chemicals, thus presenting a reduced risk of cancer and other serious health conditions when compared to traditional smokeless tobacco.

Nicotine pouches, inserted under the lip, represent the fastest-growing category within the U.S. tobacco market. They are widely regarded as among the lowest-risk alternatives to smoking because they do not involve inhalation and are tobacco-free. Altria announced that "on! PLUS will resume taking new orders for retail accounts in Florida, North Carolina and Texas and on e-commerce soon," indicating an immediate market push following the authorization.

trending

Islamabad suicide blast kills 31

trending

MRF profit doubles

trending

Thakur captains Mumbai in Quarterfinal

trending

VTU adopts Artificial Super Intelligence

trending

U19 World Cup in Harare

trending

Riyan Parag scores fifty

trending

T20 World Cup opening ceremony

trending

India A vs Namibia live

trending

Jio Hotstar buys Dhurandhar rights

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Yes, the FDA authorized the marketing of six Altria-owned on! PLUS nicotine pouch products.
The pilot program, launched in September 2025, aims to fast-track reviews for nicotine pouch products.
The FDA authorized them based on evidence of lower harmful chemical levels and reduced risk compared to other smokeless tobacco.

Read more news on

Healthside-arrow

You may also like

Sun Pharma Eyes Strategic M&A for Global Growth

1 Feb • 39 reads

article image

Maryland Fails Tobacco Prevention: ALA Report

30 Jan • 30 reads

article image

Zyn Pouches: FDA Weighs 'Reduced Risk' Claims

22 Jan • 120 reads

article image

BAT Closes SA Factory Amidst 75% Illicit Market

16 Jan • 102 reads

article image

FDA Alerts Public to Sea Moss Gel Recall

14 Jan • 106 reads

article image